EarCentric EX2 vs Elehear Beyond

The EarCentric EX2 is a behind-the-ear prescription hearing aid priced at $218, positioning it as a budget-friendly option in the prescription category. In HearAdvisor's lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking #35 of 39 prescription hearing aids tested. This 2021 release demonstrates mixed performance across key metrics. Its standout strength is feedback handling, scoring an excellent 4.7/5—essentially matching the category average and indicating reliable stability during movement. However, speech performance is a significant weakness: speech in quiet scores just 1.0/5 (2.40 points below the category average of 3.40), and speech in noise scores 1.0/5 (1.11 points below average). These low absolute scores suggest limited audibility enhancement in our standardized test conditions. Own-voice comfort scores 2.3/5, which is mixed in absolute terms and 0.40 points below the category average. Music streaming scored 0.0/5, indicating this device is not suited for audio entertainment purposes. The EarCentric EX2 may appeal to budget-conscious consumers who prioritize cost over performance, but alternatives exist at similar or lower price points with stronger test results. The RxEars Rxi, available in the same price range, scored 4.07/5 in our testing. Consumers seeking entry-level amplification should weigh the significant speech clarity limitations against the low purchase price.

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.